Disclosures: Natasha Dilwali: Nothing to Disclose, Robin Howard: Mirum Pharmaceuticals: Stock - publicly traded company, Mirum Pharmaceuticals: Consultant, Mirum Pharmaceuticals: Employee, Mirum Pharmaceuticals: Consultant, Rachel Hallum-Montes: Mirum Pharmaceuticals: Independent Contractor, Yushan Kim: GRAIL: Employee, Mirum Pharmaceuticals: Consultant, Sherlock Biosciences: Consultant, Mammoth Biosciences: Consultant, Douglas Mogul: Nothing to Disclose, Wikrom Karnsakul: Nothing to Disclose 2471 CHILDREN WITH CHRONIC HEPATITIS C HAVE A HIGH PREVALENCE OF NEURODEVELOPMENTAL DISORDERS Shreya Kishore 1 Orlee Guttman 1 , 1 British Columbia Children's Hospital Background: Chronic hepatitis C (HCV) in children is primarily acquired through vertical transmission from an HCV-infected mother
doi: 10.1111/jch.13583 139 MellBJalaVRMathewAVByunJWaghuldeHZhangYet al
This pattern was also observed in patients with treatment-resistant depression which sheds light on a very frustrating and frightening problem
Serial Changes of Serum Growth Factor Levels and Liver Regeneration after Partial Hepatectomy in Healthy Humans
The hyper-inflammatory response caused by SARS-CoV-2 induces the process of immunosenescence, increases endothelial cell damage, and leads to myofibrillar degradation and muscle wasting (sarcopenia) due to mitochondrial dysfunction and autophagy [102]